| Literature DB >> 28360025 |
Stuart Evan Bond1,2,3, Shelley P Crowther1, Suman Adhikari4,5, Adriana J Chubaty6, Ping Yu7, Jay P Borchard8, Craig Steven Boutlis9, Wilfred Winston Yeo2,3,10, Spiros Miyakis2,3,9.
Abstract
BACKGROUND: Traditional approaches to health professional education are being challenged by increased clinical demands and decreased available time. Web-based e-learning tools offer a convenient and effective method of delivering education, particularly across multiple health care facilities. The effectiveness of this model for health professional education needs to be explored in context.Entities:
Keywords: anti-bacterial agents; continuing education; medical education; nursing education; pharmacy education; survey methods; vancomycin
Mesh:
Substances:
Year: 2017 PMID: 28360025 PMCID: PMC5391435 DOI: 10.2196/jmir.6971
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Figure 1Timeline of Vancomycin Interactive design, implementation, and evaluation. ISLHD: Illawarra Shoalhaven Local Health District; SESLHD: South Eastern Sydney Local Health District.
Figure 2Filming of the Vancomycin Interactive (VI).
Figure 3Dramatic tension created the basis for the Vancomycin Interactive’s plot.
Figure 4Example of user interface for an interactive question from the Vancomycin Interactive (VI).
Number of correct responses to Web-based vancomycin knowledge survey.
| Survey question | Nurse | Doctor | Pharmacist | Total | |
| Loading dose | 46 (19.5) | 112 (41.3) | 59 (84) | <.001 | 217 (37.6) |
| Maintenance dose | 58 (24.6) | 126 (46.5) | 58 (83) | <.001 | 242 (41.9) |
| Administration rate | 152 (64.4) | 160 (59.0) | 62 (89) | <.001 | 374 (64.8) |
| First level timing | 70 (29.7) | 155 (57.2) | 59 (84) | <.001 | 284 (49.2) |
| Target trough range | 136 (57.6) | 234 (86.3) | 65 (93) | <.001 | 435 (75.4) |
| Median total score (IQRa) | 2 (1-3) | 3 (3-4) | 4 (3-4) | <.001 | 3 (2-4) |
aIQR: interquartile range.
Multivariate analysis of vancomycin knowledge survey responses (N=577).
| Topic | Profession | Experience or confidencea | |||||||
| Nurse | Doctor | Pharmacist | 1 | 2 | 3 | 4 | |||
| ORc | - | 2.6 | 16.8 | - | 1.4 | 4.6 | 11.1 | ||
| - | <.001 | <.001 | - | .25 | <.001 | <.001 | |||
| OR | - | 2.5 | 12.1 | - | 1.0 | 2.2 | 3.3 | ||
| - | <.001 | <.001 | - | .85 | .006 | .03 | |||
| OR | - | 1.0 | 2.9 | - | 2.1 | 4.7 | 5.7 | ||
| - | .82 | .01 | - | .001 | <.001 | <.001 | |||
| OR | - | 2.7 | 8.5 | - | 3.6 | 6.8 | 4.0 | ||
| - | <.001 | <.001 | - | <.001 | <.001 | .008 | |||
| OR | - | 3.9 | 5.6 | - | 3.4 | 5.7 | 5.7 | ||
| - | <.001 | .001 | - | <.001 | <.001 | .03 | |||
| - | .8 | 1.7 | - | .9j | |||||
| - | <.001 | <.001 | - | <.001 | |||||
aExperience or confidence: 1, none; 2, a little; 3, moderate; 4, very experienced or confident.
bref: reference group for multivariate analysis.
cOR: odds ratio.
dmaint dose: maintenance dose.
eadmin rate: administration rate.
flevel timing: timing of first level.
gtrough range: target range for plasma trough level.
htotal correct: nurse (all levels), doctor (all levels), pharmacist (all levels).
ib: regression coefficient.
jAverage of responses to three vancomycin experience or confidence questions, therefore a multiple regression was performed for total correct.
Number (%) of correct answers on first attempt by nurses, doctors, and pharmacists from VI data.
| Questiona | Nurse | Doctor | Pharmacist | Total | |
| 1. Loading dose | 19 (30) | 36 (42) | 9 (64) | .05 | 64 (39) |
| 2. Maintenance dose | 50 (79) | 59 (69) | 11 (79) | .32 | 120 (74) |
| 3. Compatible fluids | 53 (84) | 67 (78) | 11 (79) | .76 | 131 (80) |
| 4. Administration rate | 56 (89) | 55 (64) | 14 (100) | <.001 | 125 (77) |
| 5. Timing of first level | 20 (32) | 49 (57) | 12 (86) | <.001 | 81 (50) |
| 6. Target trough level | 47 (75) | 72 (84) | 12 (86) | .34 | 131 (80) |
| 7. Level of 35 mg/L | 43 (68) | 68 (79) | 14 (100) | .02 | 125 (77) |
| 8. Level of 20 mg/L | 49 (78) | 81 (94) | 13 (93) | .01 | 143 (88) |
| 9. Level of 26 mg/L | 46 (73) | 55 (64) | 12 (86) | .20 | 113 (69) |
| 10. Subsequent levels | 27 (43) | 45 (52) | 7 (50) | .52 | 79 (48) |
| Average score | 65% | 68% | 82% | <.001 | 68% |
aVI questions are shown in Multimedia Appendix 2.
bP values obtained using chi-square for trend.
Qualitative responses (%) following participation in the Vancomycin Interactive (VI).
| Survey statement or question | Strongly | Agree | Neutral | Disagree | Strongly disagree |
| 11 (22) | 29 (57) | 8 (16) | 3 (6) | 0 (0) | |
| Using the VI has improved my performance (n=50) | 8 (16) | 28 (56) | 12 (24) | 2 (4) | 0 (0) |
aVI: Vancomycin Interactive.